ASH: New Gilead-Arcellx data build CAR-T's case against Carvykti in advanced multiple myeloma

ASH: New Gilead-Arcellx data build CAR-T's case against Carvykti in advanced multiple myeloma gmasson Tue, 11/05/2024 - 14:18